Potential role for nitazoxanide in treating SARS-CoV-2 infection
Author:
Affiliation:
1. Investigative Pathology Laboratory, Federal University of Sergipe, Aracaju, Brazil
2. Department of Nursing, Federal University of Sergipe, Aracaju, Brazil
3. Department of Medicine, Federal University of Sergipe, Aracaju, Brazil
Publisher
American Physiological Society
Subject
Cell Biology,Physiology (medical),Pulmonary and Respiratory Medicine,Physiology
Link
https://journals.physiology.org/doi/pdf/10.1152/ajplung.00170.2020
Reference7 articles.
1. Nitazoxanide, an antiviral thiazolide, depletes ATP-sensitive intracellular Ca2+ stores
2. Efficacy and Safety of Nitazoxanide in Addition to Standard of Care for the Treatment of Severe Acute Respiratory Illness
3. Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trial
4. Nitazoxanide suppresses IL-6 production in LPS-stimulated mouse macrophages and TG-injected mice
5. Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. DFT, molecular docking and ADME prediction of tenofovir drug as a promising therapeutic inhibitor of SARS-CoV-2 Mpro;Main Group Chemistry;2023-04-05
2. A Brief Study on Drug Repurposing: New Way of Boosting Drug Discovery;Letters in Drug Design & Discovery;2023-03
3. Small Molecule Nitazoxanide Inhibits Osteogenic Differentiation and Promotes Adipogenic Differentiation of Bone Marrow Mesenchymal Stem Cells;CHIN J DENT RES;2023
4. Clinical outcomes, virological efficacy and safety of nitazoxanide in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials;Expert Review of Anti-infective Therapy;2022-11-03
5. Nitazoxanide and COVID-19: A review;Molecular Biology Reports;2022-09-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3